Kezar Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.About KZR
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD.
CEOChristopher J. Kirk
CEOChristopher J. Kirk
Employees55
Employees55
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees55
Employees55
KZR Key Statistics
Market cap46.11M
Market cap46.11M
Price-Earnings ratio-0.74
Price-Earnings ratio-0.74
Dividend yield—
Dividend yield—
Average volume29.38K
Average volume29.38K
High today$6.30
High today$6.30
Low today$6.25
Low today$6.25
Open price$6.25
Open price$6.25
Volume6.85K
Volume6.85K
52 Week high$6.93
52 Week high$6.93
52 Week low$3.53
52 Week low$3.53
Stock Snapshot
As of today, Kezar Life Sciences(KZR) shares are valued at $6.29. The company's market cap stands at 46.11M, with a P/E ratio of -0.74.
During the trading session on 2026-01-03, Kezar Life Sciences(KZR) shares reached a daily high of $6.30 and a low of $6.25. At a current price of $6.29, the stock is +0.6% higher than the low and still -0.1% under the high.
Trading volume for Kezar Life Sciences(KZR) stock has reached 6.85K, versus its average volume of 29.38K.
Over the past 52 weeks, Kezar Life Sciences(KZR) stock has traded between a high of $6.93 and a low of $3.53.
Over the past 52 weeks, Kezar Life Sciences(KZR) stock has traded between a high of $6.93 and a low of $3.53.
People also own
Based on the portfolios of people who own KZR. This list is generated using Robinhood data, and it’s not a recommendation.